Procter amp gamble Co. on Thursday said it expects to beat Wall Street's earnings expectations for its first fiscal quarter, citing strong sales of its new over the counter version of Prilosec, the Heartburn and ulcer drug.
Procter expects to beat Wall Street's forecast for first quarter earnings.